Rock Springs Capital Management’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,485,543
Closed -$11M 132
2022
Q2
$11M Buy
7,485,543
+217,847
+3% +$160K 0.32% 74
2022
Q1
$8.36M Buy
7,267,696
+3,460,034
+91% +$5.64M 0.21% 89
2021
Q4
$9.52M Buy
3,807,662
+213,777
+6% +$840K 0.22% 93
2021
Q3
$18.4M Buy
3,593,885
+582,398
+19% +$3.54M 0.39% 76
2021
Q2
$25M Buy
3,011,487
+208,533
+7% +$1.76M 0.5% 65
2021
Q1
$24.4M Buy
2,802,954
+249,746
+10% +$2.58M 0.53% 65
2020
Q4
$27.7M Buy
2,553,208
+1,549
+0.1% +$19.1K 0.59% 59
2020
Q3
$30.4M Buy
2,551,659
+447,575
+21% +$5.99M 0.77% 42
2020
Q2
$33.8M Buy
2,104,084
+149,084
+8% +$2.6M 0.93% 45
2020
Q1
$30.3M Sell
1,955,000
-95,000
-5% -$2.04M 1.25% 29
2019
Q4
$50.4M Buy
2,050,000
+199,900
+11% +$2.97M 1.59% 12
2019
Q3
$19.1M Hold
1,850,100
0.76% 50
2019
Q2
$23.2M Buy
1,850,100
+96,725
+6% +$1.24M 0.85% 46
2019
Q1
$21.7M Buy
1,753,375
+145,875
+9% +$1.63M 0.85% 43
2018
Q4
$9.9M Buy
1,607,500
+366,247
+30% +$2.8M 0.47% 69
2018
Q3
$13.2M Hold
1,241,253
0.48% 68
2018
Q2
$16.8M Sell
1,241,253
-33,747
-3% -$525K 0.65% 55
2018
Q1
$22.6M Sell
1,275,000
-50,000
-4% -$844K 0.97% 36
2017
Q4
$16.6M Sell
1,325,000
-25,000
-2% -$363K 0.75% 45
2017
Q3
$25.7M Buy
1,350,000
+175,000
+15% +$2.67M 1.19% 23
2017
Q2
$17.7M Buy
1,175,000
+605,000
+106% +$9.15M 0.9% 40
2017
Q1
$9.78M Hold
570,000
0.56% 59
2016
Q4
$6.9M Sell
570,000
-72,500
-11% -$757K 0.46% 62
2016
Q3
$6.32M Buy
642,500
+45,000
+8% +$411K 0.4% 76
2016
Q2
$6.12M Buy
597,500
+8,500
+1% +$94.8K 0.45% 72
2016
Q1
$7.14M Buy
589,000
+219,000
+59% +$2.21M 0.6% 53
2015
Q4
$5.93M Buy
370,000
+60,000
+19% +$890K 0.45% 75
2015
Q3
$3.99M Buy
310,000
+3,500
+1% +$70.6K 0.32% 94
2015
Q2
$7.36M Hold
306,500
0.54% 70
2015
Q1
$5.76M Buy
306,500
+125,000
+69% +$2.58M 0.54% 66
2014
Q4
$3.42M Buy
181,500
+50,500
+39% +$1.18M 0.4% 75
2014
Q3
$3.55M Buy
+131,000
New +$4.07M 0.55% 58

Other funds holding EPZM